Did You Know?

Editor’s Picks

Latest News

Vistagen Therapeutics, Inc. (NASDAQ: VTGN) Investor Alert: Schubert Jonckheer Investigating Possible False Claims Regarding Drug Candidate Following 80% Stock Drop

SAN FRANCISCO, April 28, 2026 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises Vistagen Therapeutics, Inc. (NASDAQ: VTGN) investors that...

Aligning Science Across Parkinson’s and The Michael J. Fox Foundation Expand Global Research Initiative with $261M Investment Toward Personalized Treatments

New funding for 32 international teams aims to unravel the complexity of Parkinson's disease and lay the groundwork for precision...

Genezen and The Charlotte & Gwenyth Gray Foundation to Cure Batten Disease Announce Manufacturing Partnership for CLN6 Gene Therapy Clinical Trial

INDIANAPOLIS and LOS ANGELES, April 28, 2026 /PRNewswire/ -- Genezen, a gene therapy contract development and manufacturing organization (CDMO), and...

error: Content is protected !!